Entity Common Stock, Shares Outstanding of AVAI BIO, INC. from 30 Jun 2018 to 12 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
AVAI BIO, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Jun 2018 to 12 Feb 2026.
  • AVAI BIO, INC. Entity Common Stock, Shares Outstanding for the quarter ending 12 Feb 2026 was 138,252,252, a 0.82% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

AVAI BIO, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 138,252,252 +1,120,672 +0.82% 12 Feb 2026 10-Q 12 Feb 2026 2026 Q3
Q3 2025 138,031,533 +16,129,091 +13% 14 Nov 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 137,511,233 +20,493,327 +18% 07 Jul 2025 10-K 08 Jul 2025 2025 FY
Q4 2024 137,131,580 +52,337,202 +62% 05 Feb 2025 10-Q 07 Feb 2025 2025 Q3
Q3 2024 121,902,442 +57,185,388 +88% 03 Sep 2024 10-Q/A 21 Jan 2025 2025 Q1
Q2 2024 117,017,906 +52,514,095 +81% 03 Jul 2024 10-K/A 19 Feb 2025 2024 FY
Q4 2023 84,794,378 +52,563,295 +163% 12 Feb 2024 10-Q 14 Feb 2024 2024 Q3
Q3 2023 64,717,054 +32,485,971 +101% 15 Aug 2023 10-Q 16 Aug 2023 2023 Q1
Q2 2023 64,503,811 +38,187,728 +145% 30 Jun 2023 10-K/A 13 Jul 2023 2022 FY
Q4 2022 32,231,083 +5,915,000 +22% 14 Feb 2023 10-Q 14 Feb 2023 2023 Q3
Q3 2022 32,231,083 +5,949,483 +23% 10 Nov 2022 10-Q 10 Nov 2022 2023 Q2
Q2 2022 26,316,083 +34,483 +0.13% 29 Jun 2022 10-K 29 Jun 2022 2022 FY
Q4 2021 26,316,083 14 Feb 2022 10-Q 14 Feb 2022 2022 Q3
Q3 2021 26,281,600 0 0% 19 Aug 2021 10-Q 23 Aug 2021 2021 Q1
Q2 2021 26,281,600 0 0% 08 Jul 2021 10-K/A 18 Aug 2021 2021 FY
Q1 2021 26,281,600 15 Feb 2021 10-Q 18 Feb 2021 2021 Q3
Q3 2020 26,281,600 +21,267,520 +424% 10 Nov 2020 10-Q 13 Nov 2020 2021 Q2
Q2 2020 26,281,600 +21,267,520 +424% 10 Aug 2020 10-K 13 Aug 2020 2020 FY
Q4 2019 5,014,080 0 0% 31 Jan 2020 10-Q 04 Feb 2020 2020 Q3
Q3 2019 5,014,080 0 0% 15 Oct 2019 10-Q/A 17 Oct 2019 2020 Q1
Q2 2019 5,014,080 +1,014,080 +25% 11 Jul 2019 10-K 15 Jul 2019 2019 FY
Q4 2018 5,014,080 31 Dec 2018 10-Q 17 Jan 2019 2019 Q3
Q3 2018 5,014,080 30 Sep 2018 10-Q 14 Nov 2018 2019 Q2
Q2 2018 4,000,000 30 Jun 2018 10-Q 25 Jul 2018 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.